SNTA - D SYNTA PHARMACEUTICALS CORP COM
This page shows which of the focused investors we track hold SNTA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2012 it was held by 1 manager with an aggregate reported value of $870K, which is 0.00% of the combined portfolio.
As of Q1 2012, 1 tracked institutional manager held SNTA (D SYNTA PHARMACEUTICALS CORP COM) with an aggregate reported value of $870K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SNTA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2012
- Ticker
- SNTA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | First Eagle - First Eagle Investment Management | 0.00% | New | 200,000 | $870K |
Loading holder history for SNTA…